|Ms. Melinda McGrath||CEO & Exec. Director||1.81M||N/A||N/A|
|Mr. James Davison||Chief Financial Officer||936.09k||N/A||N/A|
|Mr. Anthony Friedli||Chief Operating Officer||N/A||N/A||N/A|
|Mr. Sean Jackson||Chief Information Officer||N/A||N/A||N/A|
|Mr. Joe Geran||National Marketing Director||N/A||N/A||N/A|
|Associate Prof. Tony Landgren||National Medical Director & Chief Pathologist||N/A||N/A||N/A|
|Mr. Chris Brownlow||Chief Exec. Officer of New South Wales & Australian Capital Territory||N/A||N/A||N/A|
|Ms. Shae Seymour||Chief Exec. Officer of Western Australia||N/A||N/A||N/A|
|Mr. Eric Swayn||Chief Exec. Officer of South Australia & Northern Territory||N/A||N/A||N/A|
|Ms. Eleanor Padman B.A., FCIS||Company Sec.||N/A||N/A||N/A|
Australian Clinical Labs Limited provides pathology services in Australia. The company offers range of services, which include routine pathology test, advanced molecular genetics testing, harmony NIPT and first trimester screening, genetic carrier screening, chemical pathology, histopathology, and cytopathology; hematology, allergy, and immunology; serology and microbiology; and infectious molecular testing, cardiac testing services, functional pathology, veterinary pathology, and commercial drug and alcohol testing services. It offers its service to private and public hospitals. The company was incorporated in 2020 and is headquartered in Clayton, Australia.
Australian Clinical Labs Limited’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.